About Us


Our strategic partnerships enable us to bring our clients the most advanced testing techniques.

API Manufacturing and cGMP Polymer Manufacturing

Through a cooperative agreement with local universities such as Clark University in Worcester, MA, PCI also provides advanced non-GMP testing techniques including:

Clark University
Atomic Absorption (flame and graphite) spectroscopy

X-ray Crystallography

Nuclear Magnetic Resonance Spectroscopy

Differential Scanning Calorimetry

Mass Spectroscopy

GenieChem Logo
GenieChem was established in 2003 as a Speciality Chemical Distributor. The company has over 20 years experience in developing and working with new/speciality products.

We started with Axel Plastics, an internal and external release agent manufacturer, since then the portfolio of products has expanded and is much more diverse, Excel from South Wales who manufacturer grey cellulose fibre, Jelu from Germany produce white cellulose fibre as well as wood plastic composite masterbatch in both soft and hard woods, PCI, one of the leading Imidazole manufacturers in the world and last but not least, A&C Catalysts, a speciality epoxy curing agent manufacturer, who has some very niche latent hardeners among other products.

Tzamal has been at the forefront of medical technology representing some of the most distinguished medical device companies in the world, for more than 35 years. During its first 25 years, the company represented established companies and focused on direct sales. Companies which chose Tzamal to represent them include Johnson & Johnson, Ohmeda (B&D) and Schneider (Pfizer).

Just over a decade ago Tzamal embarked on a bold and new path and therefore underwent a major reorganization. The company decided to devote almost a third of its resources to representing up and coming med-techs offering unique, innovative solutions. An intensive marketing program was introduced, specifically designed to familiarize the medical community with medical innovations. Thanks to this strategy, Tzamal is today recognized for its expertise in promoting and achieving sales for young medical technology innovators. The company is proud of its unique ability to break-down barriers and guide hospital administrators throughout replacement of obsolete medical technologies with innovative ones.

Stunning results have shown the new company succeeded in surpassing the sales peak of its predecessor within half the time. Today Tzamal enjoys annual sales of over $27 million and growing. The secret of our success lies in great part in our continuous pursue for better patient care as a main goal..Our commitment to state-of-the art health care is what drives our outstanding results.

Besides marketing existing products\companies, Tzamal is also greatly involved in development of innovative new medical technologies by mentoring and financing promising medical technology start-ups in a wide variety of fields. Via its subsidiary Tzamal Investments the company is closely guiding and financing some two dozen young companies.